Table 2.
Electrophysiology in hiPSC-CM models of dACM. For each mutation studied in hiPSC-CMs for which data are available, we summarized findings related to cardiomyocyte electrical activity, including molecular and functional data for individual ion channels and parameters related to excitation, conduction, and synchrony in multicellular preparations. Mutations are given in p-dot (p.) nomenclature and specified as T (truncating) or M (missense). Symbols and colors are described below the information presented in the table and comparisons are represented as mutant cell lines relative to control cell lines under the same conditions as presented by the data published in the primary sources, for which references are provided.
| Molecular Data | Single Channel Currents | Excitation, Conduction, & Synchrony | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene | Mutation | SCN5A/Nav1.5 | GJA/Cx43 | SK3/KCa2.3 | SK4/KCa3.1 | KCNJ11/Kir6.2 | KCNQ1/Kv7.1 | KCNJ2/Kir2.1 | KCNH2/Kv11.1 | SLC8A1/NCX1 | INa | ICaL | INCX | Ito | IK | Ikr | Iks | ISK | ISK4 | IKATP | AP probability | Resting potential | AP upstroke velocity | AP upstroke heterogeneity | AP amplitude | AP duration | AP frequency | Conduction velocity | Arrhythmic events | Refs. |
| PKP2 | p.G828LfsX835 | ▽ | ▼ | ■ | ▼ | ▼ | ■ | [28,68] | ||||||||||||||||||||||
| p.A324fsX355 | ▼ | ▼ | [58] | |||||||||||||||||||||||||||
| p.Y119MfsX141 + p.K859R | ■■□ | ▼ | ▼ | ■ | [84] | |||||||||||||||||||||||||
| p.D109AfsX119 * | ▼ | ▲ | [85] | |||||||||||||||||||||||||||
| p.D109AfsX119 * | ▼ | ▲ | ||||||||||||||||||||||||||||
| DSG2 | p.G638R † | ▽ | ▽ | ▲△ | ▽ | ▼ | ■ | ▼ | ▼ | ▲ | ■ | ▼ | ▲ | ▼ | ■ | ▼ | ▼ | ■ | ▲ | ▲ | [89,182] | |||||||||
| p.D787MfsX807 | △ | □ | △ | □ | □ | ■ | ▲ | ▼ | ■ | [59] | ||||||||||||||||||||
| p.R119X | ▼ | ▲ | [90] | |||||||||||||||||||||||||||
| DSP | p.R451G | ▼ | ■ | [91] | ||||||||||||||||||||||||||
| p.H1684R | ▼ | ▼ | ▲ | ▼ | ▼ | ▼ | [92] | |||||||||||||||||||||||
| DSC2 | p.R132C | △ | △ | ▼ | ▲ | ■ | ■ | ■ | ▼ | ▲ | ▲ | [88,185,186] | ||||||||||||||||||
| Heterozygous mutation (not shaded) | ▼ decreased relative to control | |||||||||||||||||||||||||||||
| Compound heterozygous mutation (shaded red) | ■ no change relative to control | |||||||||||||||||||||||||||||
| Homozygous mutation (shaded blue) | ▲ increased relative to control | |||||||||||||||||||||||||||||
| ▲■▼ membrane protein (immunofluoresence) | ||||||||||||||||||||||||||||||
| * Artificially introduced mutation (not patient derived) | ▲■▼ total protein abundance (Western blot) | |||||||||||||||||||||||||||||
| † Assumed heterozygous, although not specified | △□▽ total mRNA abundance (qPCR/RNA-seq) | |||||||||||||||||||||||||||||